Duality of glucocorticoid action in cancer: tumor-suppressor or oncogene?


Glucocorticoid receptor (GR) is a key homeostatic regulator involved in governing immune response, neuro-integration, metabolism and lung function. In conjunction with its pivotal role in human biology, GR action is critically linked to the pathology of various disease types, including cancer. While pharmacological activation of GR has been used for the treatment of various liquid cancers, its role in solid cancers is less clearly defined and seems to be cancer-type dependent. This review focuses on the molecular aspects of GR biology, spanning the structural and functional basis of response to glucocorticoids, as well as how this transcription factor operates in cancer, including the implications in disease development, progression and drug resistance.

More about this publication

Endocrine-related cancer
  • Volume 28
  • Issue nr. 6
  • Pages R157-R171
  • Publication date 11-05-2021

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.